Delivery Order SPE2DR25D2014-SPE2DR26FA0F7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on July 21, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is a specialized pharmaceutical used in the treatment of prostate cancer, reflecting...
- The Defense Logistics Agency awarded a $18.17K delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This firm fixed-price, non-set-aside contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of November 28, 2025. Yonsa (abiraterone acetate) is a prescription medication used in the treatment of castration-resistant prostate cancer, representing the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $2,393.67. The order is scheduled for ultimate completion by December 26, 2025, and utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on October 20, 2025, with an ultimate completion date of November 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $4,542.74 and completion date of July 11, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $11,356.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Yonsa 125 mg on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-competitive delivery order was placed against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a 120-count quantity. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for Yonsa 125 mg tablets (120-count supply) with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0F7Delivery Order
This delivery order awards AmerisourceBergen Drug Corp $2,393.67 for the supply of Yonsa 125 mg tablets (120-count units) under a firm fixed-price contract with the Defense Logistics Agency (DLA). The award, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, represents a non-competitive, non-set-aside procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. Yonsa (abiraterone acetate) is an oral medication used in the treatment of castration-resistant prostate cancer, indicating this order supports military or federal healthcare system needs for oncology pharmaceuticals. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that supplies comprehensive pharmaceutical and medical products globally to support military healthcare programs. As a major pharmaceutical distributor serving federal medical procurement, AmerisourceBergen Drug Corp leverages this expansive IDC vehicle to fulfill ongoing federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/17/25 |